FDA Approves Drug to Stop Some Malaria Relapses

U.S. regulators Friday approved a simpler, one-dose treatment to prevent relapses of malaria. Standard treatment now takes two weeks and studies show many patients don’t finish taking every dose. Malaria is caused by parasites that are spread to people through mosquito bites. Anti-malarial drugs can cure the initial infection, but parasites can get into the liver, hide in a dormant form and cause recurrences months or years later. A second drug is used to stop relapses. The new...

© La Voix de l'Amérique - samedi 21 juillet 2018